Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
WEBINAR: Recent Advancements In Neurodegenerative Biomarkers
Sep 6, 2021
Recent Advancements in Neurodegenerative Biomarkers: Progress Towards a Diagnostic Blood Test for Alzheimer’s Disease
How to Improve Your Viral Nucleic Acid Extraction Processes
Sep 6, 2021
High-Throughput Extraction with CyBio FeliX
Introducing New Aura 4.0 software
Aug 31, 2021
With new features for both acquisition & analysis Aura Software enables you to capture and analyze your data quickly,...
Comparison of gamma and x-ray irradiation results
Aug 12, 2021
Biological effects of Cs-137 and X-ray irradiators are comparable with regards to...
Hypoxia further exacerbates myopathy in broilers via alteration of satellite cell fate
Aug 2, 2021
Woody breast (WB) condition has created a variety of challenges for the global poultry...
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence,...
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jul 15, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full...
ACCELA webinar recording : IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jul 15, 2021
Intravital microscopy can visualize...
Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry
Jul 15, 2021
One of the key advantages of spectral flow cytometry is its ability to extract sample...
Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease
Jul 9, 2021
Understanding how cells organize the array of components within their membranous confines can not only provide insight...
Registering FDG/PET mouse and AMYViD/PET-CT rat studies to brain VOI atlases
May 22, 2018
Preclinical NeuroPET is employed widely in studies of stroke, ischemia, addiction and neurodegenerative diseases. A wide range of tracers are used in NeuroPET studies. In both clinical and preclinical imaging, 18FDG is frequently used as a biomarker of brain function in models of neurological disorders. Targeted tracers such as the recently FDA approved Florbetapir F18 (AMYViD) amyloid tracer provide specific activity. Additionally, using both post synaptic and pre synaptic specific tracers, researchers can make in vivo measurements of neurotransmitter function.
Do you want to learn more? Read the whole article!
Brand profile
